Clinical Trial Update: Metabolic and Immunomic Differential Analysis of Primary Central Nervous System Diffuse Large B-Cell Lymphoma

View source ↗

Summary

A recruiting clinical study examining metabolic and immunomic differences in primary central nervous system lymphoma and diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma
• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Ting YANG | Conditions: Primary Central Nervous System Lymphoma (PCNSL), Diffuse Large B-Cell Lymphoma | Status: RECRUITING